Advanced glycation end products (AGE) and diabetes: cause, effect, or both?
about
Visceral adiposity syndromeNatural Phyto-Bioactive Compounds for the Treatment of Type 2 Diabetes: Inflammation as a TargetDietary advanced glycation end products and their role in health and diseaseDifferential effects of glycation on protein aggregation and amyloid formation.Nutritional psychiatry research: an emerging discipline and its intersection with global urbanization, environmental challenges and the evolutionary mismatchAssociation between hemoglobin glycation index with insulin resistance and carotid atherosclerosis in non-diabetic individuals.Advanced glycation end products and oxidative stress in type 2 diabetes mellitus.Effect of advanced glycosylation end products on apoptosis in human adipose tissue-derived stem cells in vitro.The AGE-RAGE Axis and Its Relationship to Markers of Cardiovascular Disease in Newly Diagnosed Diabetic Patients.Increased skin autofluorescence of children and adolescents with type 1 diabetes despite a well-controlled HbA1c: results from a cohort studyCarboxymethyl lysine, an advanced glycation end product, and incident diabetes: a case-cohort analysis of the ARIC Study.Crosstalk between advanced glycation end products (AGEs)-receptor RAGE axis and dipeptidyl peptidase-4-incretin system in diabetic vascular complications.Protein pathways working in human follicular fluid: the future for tailored IVF?Effect of diet-derived advanced glycation end products on inflammation.NADPH Oxidases in Chronic Liver DiseasesThe influence of processed meat consumption on chronic obstructive pulmonary disease.Glycative stress from advanced glycation end products (AGEs) and dicarbonyls: An emerging biological factor in cancer onset and progression.Protective role of sulphoraphane against vascular complications in diabetes.Diabetes mellitus in patients with cirrhosis: clinical implications and management.Hepatogenous diabetes: Is it time to separate it from type 2 diabetes?Phlorotannins: Towards New Pharmacological Interventions for Diabetes Mellitus Type 2.Carbonyl trapping and antiglycative activities of olive oil mill wastewater.Consumption of Unprocessed and Processed Red Meat and the Risk of Chronic Obstructive Pulmonary Disease: A Prospective Cohort Study of Men.Effects of age-related shifts in cellular function and local microenvironment upon the innate immune response to implants.Dietary Advanced Glycation End Products and Cardiometabolic Risk.Rosmarinic acid modulates the antioxidant status and protects pancreatic tissues from glucolipotoxicity mediated oxidative stress in high-fat diet: streptozotocin-induced diabetic rats.N-acetylcysteine Counteracts Adipose Tissue Macrophage Infiltration and Insulin Resistance Elicited by Advanced Glycated Albumin in Healthy Rats.The Protective Effect of Antioxidants Consumption on Diabetes and Vascular ComplicationsMatrine-Type Alkaloids Inhibit Advanced Glycation End Products Induced Reactive Oxygen Species-Mediated Apoptosis of Aortic Endothelial Cells In Vivo and In Vitro by Targeting MKK3 and p38MAPK Signaling.A Retrospective Study in Adults with Metabolic Syndrome: Diabetic Risk Factor Response to Daily Consumption of Agaricus bisporus (White Button Mushrooms).Advanced glycation end-products (AGEs) and associations with cardio-metabolic, lifestyle, and dietary factors in a general population: the NQplus study.Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms.Attenuation of Glucose-Induced Myoglobin Glycation and the Formation of Advanced Glycation End Products (AGEs) by (R)-α-Lipoic Acid In Vitro.Advanced Glycation-Modified Human Serum Albumin Evokes Alterations in Membrane and Eryptosis in Erythrocytes.Peripheral Levels of AGEs and Astrocyte Alterations in the Hippocampus of STZ-Diabetic Rats.Serum Fluorescent Advanced Glycation End (F-AGE) products in gestational diabetes patients.Evaluation of methylglyoxal toxicity in human erythrocytes, leukocytes and platelets.Potential involvement of dietary advanced glycation end products in impairment of skeletal muscle growth and muscle contractile function in mice.Advanced glycation end products-induced insulin resistance involves repression of skeletal muscle GLUT4 expression.Neuronal damage and shortening of lifespan in C. elegans by peritoneal dialysis fluid: Protection by glyoxalase-1.
P2860
Q26738890-D2174FE9-8F95-48BE-8FF0-1A69845AA675Q26741391-5B63D48F-3AB6-4CFB-9748-67FCEAE23F63Q26801247-2208DE0D-2AC8-4878-84C2-116162241607Q30374807-3C413746-BAB8-421D-A388-357592CFB7CFQ30838578-843364B0-5FD3-4FDD-B566-08C4FE88A7CBQ33584606-D360C885-1EDF-4219-B8BB-EC85BE13F761Q35255473-E3FAA93C-5E97-4659-8165-BC89FDA0B422Q35600704-F0A0DD78-7FE3-48A8-B95A-55A131AA1EEEQ36081850-C28A5BDF-5911-490B-8C30-EDEC7D794696Q36128952-298F686A-3916-45ED-B840-C3948B89DB3EQ37056383-1B630421-9E08-4F3F-BC42-E0716B216D2FQ38315999-42CD4025-74F4-4831-972E-1BADD2B87D13Q38447792-6C534982-A1C5-4DA3-94E0-4B43DD9D4FC5Q38588208-2E6C9AEA-497C-4976-B4ED-C96D9857A384Q38599090-AB9C1B7B-74B5-4269-8F3A-781867763044Q38616696-CF63AD3B-6EDF-4439-9904-5E032468ED36Q38698770-B6A50D2E-A0CE-4FA8-91DE-A60B0D48A9C6Q38721709-8BD1DFB7-B80E-4838-999B-9C950114835CQ38773241-BB640A96-ED05-40BE-AB64-88F2AB30E50BQ39036315-C2C91778-F2C8-43C6-9C7B-F9C52DDD627EQ39064669-8A73DC23-A9C8-428E-B18A-6A4DDBAC698DQ39073641-F6060D5E-5AE7-4851-9B06-AE91E62F6181Q39241882-5731FD6B-4B8E-4D20-8B36-A243E2355704Q39327060-50DA43F8-7C33-42AC-8056-C6C05B377E4FQ39427655-B431219C-7278-4D77-B9D0-544B0252EE87Q41307634-A61969F5-D72B-4AD6-BFE4-B25BA9E685EBQ42161720-0213D93D-F214-4A38-9C1E-AB510708A08EQ42226832-04F7F5A2-2C65-4EF7-9C75-70105D7952FAQ46249392-9F5BD5B2-7488-41C4-ABE4-FDCA8A865380Q47427273-EBAA61FC-BAB4-4DFC-B852-9E97B61B3C7CQ48178877-113E5585-AFAB-4942-8AAB-326EF67B5883Q49833824-C49873BC-1E8D-48E9-A0BB-97C3605C9F39Q50117388-51078803-8386-411A-9A64-D9C47278593BQ50438327-3822E45F-519F-4B83-93AF-532C1063A011Q50655623-914EE355-7FCF-4246-A192-D8589FBF4E16Q51127315-26DCD903-AE04-4A33-97D1-CFCE249D3ED5Q51175353-4A302395-532F-4517-971F-C0C5020B7F22Q51187983-C48C972F-E7F6-422E-8145-BF1778FD810BQ54986288-FC636B52-EBE4-490A-871C-4CD42DADAB79Q55075595-1FA9449A-A0E2-41BA-9FFB-0A08B95A7F8D
P2860
Advanced glycation end products (AGE) and diabetes: cause, effect, or both?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Advanced glycation end products (AGE) and diabetes: cause, effect, or both?
@en
Advanced glycation end products (AGE) and diabetes: cause, effect, or both?
@nl
type
label
Advanced glycation end products (AGE) and diabetes: cause, effect, or both?
@en
Advanced glycation end products (AGE) and diabetes: cause, effect, or both?
@nl
prefLabel
Advanced glycation end products (AGE) and diabetes: cause, effect, or both?
@en
Advanced glycation end products (AGE) and diabetes: cause, effect, or both?
@nl
P2860
P1476
Advanced glycation end products (AGE) and diabetes: cause, effect, or both?
@en
P2093
Helen Vlassara
Jaime Uribarri
P2860
P2888
P356
10.1007/S11892-013-0453-1
P577
2014-01-01T00:00:00Z